Partial heart transplantation for pediatric heart valve dysfunction: A clinical trial protocol
PLOS ONE · 07.02.2023 · 18 (2) · e0280163
DOI: 10.1371/journal.pone.0280163 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift PLOS ONE, online erschienen am 07.02.2023. Verfasst von Taufiek Konrad Rajab und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Cardiothoracic Surgery, Department of Surgery, Medical University of South Carolina, Charleston, South Carolina, United States …. Hauptthemen laut MEDLINE: Heart Transplantation, Heart Valve Prosthesis Implantation, Pulmonary Valve. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, NHLBI Division of Intramural Research.
Abstract (Originalsprache)
Congenital heart defects are the most common type of birth defects in humans and frequently involve heart valve dysfunction. The current treatment for unrepairable heart valves involves valve replacement with an implant, Ross pulmonary autotransplantation, or conventional orthotopic heart transplantation. Although these treatments are appropriate for older children and adults, they do not result in the same efficacy and durability in infants and young children for several reasons. Heart valve implants do not grow with the. Ross pulmonary autotransplants have a high mortality rate in neonates and are not feasible if the pulmonary valve is dysfunctional or absent. Furthermore, orthotopic heart transplants invariably fail from ventricular dysfunction over time. Therefore, the treatment of irreparable heart valves in infants and young children remains an unsolved problem. The objective of this single-arm, prospective study is to offer an alternative solution based on a new type of transplant, which we call “partial heart transplantation.” Partial heart transplantation differs from conventional orthotopic heart transplantation because only the part of the heart containing the heart valve is transplanted. Similar to Ross pulmonary autotransplants and conventional orthotopic heart transplants, partial heart transplants contain live cells that should allow it to grow with the recipient child. Therefore, partial heart transplants will require immunosuppression. The risks from immunosuppression can be managed, as seen in conventional orthotopic heart transplant recipients. Stopping immunosuppression will simply turn the growing partial heart transplant into a non-growing homovital homograft. Once this homograft deteriorates, it can be replaced with a durable adult-sized mechanical implant. The protocol for our single-arm trial is described. The ClinicalTrials.gov trial registration number is NCT05372757 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Pediatric Cardiothoracic Surgery, Department of Surgery, Medical University of South Carolina, Charleston, South Carolina, United States of America.
- College of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.
- Division of Pediatric Cardiology, Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina, United States of America.
- Department of Surgery, Duke University Hospitals, Durham, North Carolina, United States of America.
ORCID-Profile: Brielle Ochoa, Kasparas Zilinskas
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
- NHLBI Division of Intramural Research
- American Association for Thoracic Surgery
- Brett Boyer Foundation
- Saving Tiny Hearts Society
- Emerson Rose Heart Foundation
Zitieren
APA
Rajab, T. K., Ochoa, B., Zilinskas, K., Kwon, J., Taylor, C. L., Henderson, H. T., Savage, A. J., Kavarana, M., Turek, J. W., & Costello, J. M. (2023). Partial heart transplantation for pediatric heart valve dysfunction: A clinical trial protocol. PLOS ONE, 18(2), e0280163. https://doi.org/10.1371/journal.pone.0280163
Vancouver
Rajab TK, Ochoa B, Zilinskas K, Kwon J, Taylor CL, Henderson HT, et al. Partial heart transplantation for pediatric heart valve dysfunction: A clinical trial protocol. PLOS ONE. 2023;18(2):e0280163. doi:10.1371/journal.pone.0280163
BibTeX
@article{Rajab2023,
author = {Rajab, Taufiek Konrad and Ochoa, Brielle and Zilinskas, Kasparas and Kwon, Jennie and Taylor, Carolyn L and Henderson, Heather T and Savage, Andrew J and Kavarana, Minoo and Turek, Joseph W and Costello, John M},
title = {Partial heart transplantation for pediatric heart valve dysfunction: A clinical trial protocol},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {2},
pages = {e0280163},
doi = {10.1371/journal.pone.0280163}
}
EUVIMED